PURPOSE OF REVIEW: To present an updated summary of the relationship between inflammation and localized and generalized bone loss in the rheumatic diseases. RECENT FINDINGS: In addition to the well established role of inflammatory cytokines in promoting enhanced osteoclast function and bone loss, recent work has discovered the cytokine milieu may also inhibit osteoblast function and bone repair. The WNT and bone morphogenetic protein pathways provide molecular links between inflammation and altered bone homeostasis in chronic inflammatory states. These pathways and others have been the targets of emerging therapies for the management of inflammatory bone loss. SUMMARY: Inflammation and bone loss are linked through a number of molecular pathways. Both of these processes need to be addressed when designing an effective treatment strategy for the rheumatic diseases.
PURPOSE OF REVIEW: To present an updated summary of the relationship between inflammation and localized and generalized bone loss in the rheumatic diseases. RECENT FINDINGS: In addition to the well established role of inflammatory cytokines in promoting enhanced osteoclast function and bone loss, recent work has discovered the cytokine milieu may also inhibit osteoblast function and bone repair. The WNT and bone morphogenetic protein pathways provide molecular links between inflammation and altered bone homeostasis in chronic inflammatory states. These pathways and others have been the targets of emerging therapies for the management of inflammatory bone loss. SUMMARY:Inflammation and bone loss are linked through a number of molecular pathways. Both of these processes need to be addressed when designing an effective treatment strategy for the rheumatic diseases.
Authors: Timothy A Petrie; Nicholas S Strand; Chao-Tsung Yang; Chao Tsung-Yang; Jeremy S Rabinowitz; Randall T Moon Journal: Development Date: 2014-07 Impact factor: 6.868
Authors: Jared A Niska; Jonathan H Shahbazian; Romela Irene Ramos; Kevin P Francis; Nicholas M Bernthal; Lloyd S Miller Journal: Antimicrob Agents Chemother Date: 2013-08-05 Impact factor: 5.191
Authors: Armaun J Emami; Chrisoula A Toupadakis; Stephanie M Telek; David P Fyhrie; Clare E Yellowley; Blaine A Christiansen Journal: J Bone Miner Res Date: 2018-09-24 Impact factor: 6.741
Authors: Marie A Labouesse; Erik R Gertz; Brian D Piccolo; Elaine C Souza; Gertrud U Schuster; Megan G Witbracht; Leslie R Woodhouse; Sean H Adams; Nancy L Keim; Marta D Van Loan Journal: Bone Date: 2014-04-04 Impact factor: 4.398
Authors: A Del Fattore; A Cappariello; M Capulli; N Rucci; M Muraca; F De Benedetti; A Teti Journal: Osteoporos Int Date: 2013-08-14 Impact factor: 4.507